Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: Influence on prognosis

Urology

Volumn 47, Issue 2, 1996, Pages 218-224

  Bratt, Ola ^a   Anderson, Harald ^b   Bak Jensen, Elisabeth ^b   Baldetorp, Bo ^b   Lundgren, Rolf ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL CYCLE S PHASE; CYTOGENETICS; DNA CONTENT; DNA DETERMINATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; METAPHASE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0029868377     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80420-8     Document Type: Article

References (26)

1. Rowley JD: Molecular cytogenetics: Rosetta stone for understanding cancer-twenty-ninth G.H.A. Clowes memorial awards lecture. Cancer Res 50: 3816-3825, 1990.
2. Rodriguez E, Sreekantaiah C, and Chaganti RS: Genetic changes in epithelial solid neoplasia. Cancer Res 54: 3398-3406, 1994.
3. Lundgren R, Heim S, Mandahl N, Anderson H, and Mitelman F: Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients. J Urol 147: 784-788, 1992.
4. Adolfsson J: Prognostic value of deoxyribonucleic acid content in prostate cancer: a review of current results. Int J Cancer 58: 211-216, 1994.
5. Schröder F, Tribukait B, Böcking A, DeVere White R, Koss L, Lieber M, Stenkvist B, and Zetterberg A: Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer, Stockholm, Sweden, May 12-13, 1993. Scand J Urol Nephrol Suppl 162: 51-63, 1994.
6. Koss LG, Czerniak B, Herz F, and Wersto RP: Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. Hum Pathol 20: 528-548, 1989.
7. Sigurdsson H, Baldetorp B, Borg Å, Dahlberg M, Fernö M, Killander D, and Olsson H: Indicators of prognosis in node-negative breast cancer. N Engl J Med 322: 1045-1053, 1990.
8. Friberg LG, Norén H, and Delle U: Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year study. Gynecol Oncol 53: 64-69, 1994.
9. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, and Mitelman F: Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosom Cancer 4: 16-24, 1992.
10. Mostofi FK, Sesterhenn I, and Sobin LH: Histological typing of prostate tumours. International histological classification of tumors. No 22, WHO, Geneva, 1980.
11. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, and Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathologic material using flow cytometry. J Histochem Cytochem 31: 1333-1335, 1983.
12. Schutte B, Reynders MM, Bosman FT, and Blijham GH: Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 6: 26-30, 1985.
13. Baldetorp B, Dahlberg M, Holst U, and Lindgren G: Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry 10: 695-705, 1989.
14. Hiddeman W, Schuman J, Andreeff M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, and Sandberg AA: Convention on nomenclature for DNA cytometry. Cytometry 5: 445-446, 1984.
15. Baisch H, Godhe W, and Linden WA: Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys 12: 31-39, 1975.
16. O'Malley FP, Grignon DJ, Keeney M, Kerkvliet N, and McLean C: DNA heterogeneity in prostatic carcinoma. A DNA flow cytometric mapping study with whole organ sections of prostate. Cancer 71: 2797-2802, 1993.
17. Breitkreuz T, Romanakis K, Lutz S, Seitz G, Bonkhoff H, Unteregger G, Zwergel T, Zand KD, and Wullich B: Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Res 53: 4035-4040, 1993.
18. König JJ, Teubel W, van Dongen JW, Hagemeijer A, Romijn JC, and Schröder FH: Tissue culture loss of aneuploid cells from carcinomas of the prostate. Genes, Chromosom Cancer 8: 22-27, 1993.
19. Hedley DW: Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 10: 229-241, 1989.
20. Persons DL, Gibney DJ, Katzman JA, Lieber MM, Farrow GM, and Jenkins RB: Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma. J Urol 150: 120-125, 1993.
21. Visakorpi T, Kallioniemi OP, Paronen IY, Isola JJ, Heikkinen AI, and Koivula TA: Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy. Br J Cancer 64: 578-582, 1991.
22. Centeno BA, Zietman AL, Shipley WU, Sobczak ML, Shipley JW, Preffer FI, Boyle BJ, and Colvin RB: Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 30: 309-315, 1994.
23. Vesalainen S, Nordling S, Lipponen P, Talja M, and Syrjänen K: Progression and survival in prostatic adenocarcinoma: a comparision of clinical stage, Gleason grade, S-phase fraction and DNA ploidy. Br J Cancer 70: 309-314, 1994.
24. Visakorpi T: Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J Pathol 168: 7-13, 1992.
25. van den Ouden D, Tribukait B, Blom JH, Fossa SD, Kurth KH, ten Kate FJ, Heiden T, Wang N, and Schröder FH: Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. The European Organization for Research and Treatment of Cancer Genitourinary Group. J Urol 150: 400-406, 1993.
26. Silvestrini R: Quality control for evaluation of the S-phase fraction by flow cytometry: a multicentric study. The SICCAB Group for Quality Control of Cell Kinetic Determinations. Cytometry 18: 11-16, 1994.